Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Clinical parameters of TNBC with basal-like breast cancer (BLBC) or non-BLBC phenotype

From: A clinically relevant gene signature in triple negative and basal-like breast cancer

Parameter Information available*   Non-BLBC
(n= 107, 27.2%)
BLBC
(n= 287, 72.8%)
Total (n= 394) P-value
lymph node status n = 308 LNN 50 (64.9%) 190 (82.3%) 240  
   N1 27 (35.1%) 41 (17.7%) 68 0.002
Age 50 yrs n = 309 ≤ 50 yr 27 (34.6%) 124 (53.7%) 151  
   > 50 yr 51 (65.4%) 107 (46.3%) 158 0.004
Tumor size n = 309 ≤ 2 cm 16 (20.5%) 69 (29.9%) 85  
   > 2 cm 62 (79.5%) 162 (70.1%) 224 0.14
Histological grade n = 309 G3 45 (57.0%) 182 (79.1%) 227  
   G1&2 34 (43.0%) 48 (20.9%) 82 < 0.001
  1. * Number of cases with available information on the specific parameter in the finding cohort-A